Trademarkia Logo

Australia

AU$
Trademark Search
SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES
SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES
Not protected: Not accepted

Last updated on 20 Jan 2024

Owner Info

HYBRID CONCEPTS INTERNATIONAL, LLC

2135 BEDELL ROAD, SUITE 9B

GRAND ISLAND NY 14072, UNITED STATES OF AMERICA

Serial Number

2303923 filed on 6 Jun 2022

Correspondent

JOHN P. MURTAUGH Pearne & Gordon LLP

1801 East 9th Street, Suite 1200,

Cleveland OH 44114-3108,

UNITED STATES OF AMERICA

SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

Classification Information


Class [035]
Assistance, advisory services and consultancy with regard to business planning; business consulting and management in the field of clinical trials, na Read More

Class [036]
Financial consulting services, namely, advising others regarding intellectual property investments; investment consultation in the fields of product, Read More

Class [042]
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of Read More

Class [044]
Consulting services in the field of health; consulting services to health care providers in the field of treating life-changing or life-threatening di Read More

Mark Details


Serial Number

2303923

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Dec 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
20th Jan 2024International Registration in Australia Refused correspondence sent
19th Jan 2024Status change to Lapsed/Not Protected
12th Jan 2024IP Right Goods and Services Items updated
12th Jan 2024IP Right Goods and Services Items updated
12th Jan 2024IP right goods and service classes updated
13th Oct 2023IRDA - Opposition Still Possible Notice correspondence sent
20th Jul 2023Customer Amendment Made correspondence sent
20th Jul 2023Amendment to Address for Service Requested
13th Oct 2022Adverse Report (Examination) correspondence sent
12th Oct 2022IP Right has been Examined